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ABSTRACT
The muscle mass-specific mean power output (PMMS,mean) during
push-off in jumping in marmosets (Callithrix jacchus) is more than
twice that in humans. In the present study it was tested whether this is
attributable to differences in muscle contractile properties. In biopsies
of marmoset m. vastus lateralis (VL) and m. gastrocnemius medialis
(GM) (N=4), fibre-type distribution was assessed using fluorescent
immunohistochemistry. In single fibres from four marmoset and
nine human VL biopsies, the force–velocity characteristics were
determined. Marmoset VL contained almost exclusively fast muscle
fibres (>99.0%), of which 63% were type IIB and 37% were hybrid
fibres, fibres containing multiple myosin heavy chains. GM contained
9% type I fibres, 44% type IIB and 47% hybrid muscle fibres. The
proportions of fast muscle fibres in marmoset VL and GM were
substantially larger than those reported in the corresponding human
muscles. The curvature of the force–velocity relationships ofmarmoset
type IIB and hybrid fibres was substantially flatter than that of human
type I, IIA, IIX and hybrid fibres, resulting in substantially higher
muscle fibre mass-specific peak power (PFMS,peak). Muscle mass-
specific peak power output (PMMS,peak) values of marmoset whole VL
and GM, estimated from their fibre-type distributions and force–
velocity characteristics, were more than twice the estimates for the
corresponding humanmuscles. As the relative difference in estimated
PMMS,peak between marmosets and humans is similar to that of PMMS,
mean during push-off in jumping, it is likely that the difference in in vivo
mechanical output between humans andmarmosets is attributable to
differences in muscle contractile properties.
KEY WORDS: Primate, Comparative physiology, Muscle mass-
specific power, Force–velocity relationship, Immunohistochemistry,
Muscle fibre-type distribution, Myosin heavy chain, Single muscle
fibre, Skinned muscle fibre
INTRODUCTION
In the animal kingdom there are large differences among species
in performance during vertical jumping (Marsh and John-Alder,
1994; Aerts, 1998; Harris and Steudel, 2002; Legreneur et al., 2010;
Bobbert et al., 2014). For comparison among different species,
the performance of jumping is best defined as body mass-specific
mean power output (PBMS,mean) or leg muscle mass-specific mean
power output (PMMS,mean) during push-off. Recently, in vivo mean
power output during the push-off in vertical jumping of the common
marmoset, Callithrix jacchus (Linnaeus 1758), was shown to be
52 W kg−1 PBMS,mean and 430 W kg
−1 PMMS,mean (Bobbert et al.,
2014). These values are twice those reported for humans (Homo
sapiens L.; 27 W kg−1 PBMS,mean and 181 W kg
−1 PBMS,mean,
respectively; Bobbert et al., 2014).
The higher power-generating capacity of marmosets may be
explained by a larger proportion of fast muscle fibres and/or
differences in force–velocity (F–V ) characteristics of the muscle
fibres. In general, the major leg muscles consist of higher percentages
of fast-type fibres in smaller primates, such as rhesus monkey
(Macaca mulatta), green vervet monkey (Chlorocebus aethiops
sabaeus) and bushbaby (Galago senegalensis), than in larger
primates such as humans (Ariano et al., 1973; Green et al., 1981;
Petter and Jouffroy, 1993; Fitts et al., 1998; Jouffroyet al., 1999; Feng
et al., 2012). Moreover, based on reports on muscle fibre-type
distribution, in small primates one of themajor legmuscles,m. vastus
lateralis (VL), seems to consist of relatively large proportions of fast
glycolytic fibre types [fibres expressing IIB and IIX, myosin heavy
chain (MHC) not distinguished] (Ariano et al., 1973; Petter and
Jouffroy, 1993; Feng et al., 2012). However, little is known regarding
the muscle fibre F–V characteristics within small primates. Tracing
differences in in vivo mechanical output to differences in muscle
contractile properties it is not sufficient to reveal muscle fibre-type
distribution – one also needs information about muscle fibre F–V
characteristics. Some reports on F–V characteristics of skinned
muscle fibre segments from primates suggest that the maximal
shortening velocity (Vmax) of type IIA fibres is higher in small primate
species (e.g. green vervet monkey and rhesus monkey) than in
humans, whilst specific tension (P0) seems to be similar (Larsson and
Moss, 1993; Bottinelli et al., 1996; Fitts et al., 1998; Gilliver et al.,
2009; Choi et al., 2012). However, to the best of our knowledge, there
are no data available on the F–V characteristics of fast glycolytic
muscle fibres (type IIB and IIX) of the smallest primates.
The aimof this studywas to investigatewhether the2-folddifference
in in vivomean poweroutput (bothPBMS,mean andPMMS,mean) between
marmosets and humans is attributable to differences in muscle
contractile properties. First, fibre-type distributions were assessed
within marmoset m. vastus lateralis (VL) and m. gastrocnemius
medialis (GM). Subsequently, F–V characteristics of marmoset and
human single muscle fibre segments were determined. From these
data, estimates of muscle mass-specific peak power (PMMS,peak) were
calculated for marmoset VL and GM and compared with those for
humans.
RESULTS
Fibre-type distribution of marmoset VL and GM
Immunohistochemical staining of cross-sections of marmoset VL
biopsies showed that a very small number of muscle fibresReceived 28 November 2014; Accepted 8 May 2015
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expressed type I MHC (0.2±0.05% in the distal region of VL and
1.1±0.53% in the proximal region). In VL, 68.9±5.1% (distal)
and 56.5±7.50% (proximal) of the fibres were pure type IIB
fibres, while the remaining fibres were hybrid fibres, expressing
multiple MHCs.
InGM, the proportion of type I fibres (8.6±1.9% in the distal region
and 9.7±5.3% in the proximal region) was also very small. In GM,
48.0±4.5% (distal) and 40.6±12.37% (proximal) of the muscle fibres
expressed type IIBMHCexclusively. The proportions of the different
fibre types are summarized in Fig. 1 and Table 1. No main effects for
muscle and region and no interaction effects were found.
Marmoset optimal sarcomere length
To measure F–V characteristics around optimal sarcomere length,
we determined the optimal sarcomere length by measuring the
length–force characteristics of five muscle fibre segments. Force
deterioration due to transferring the fibre from relaxing to activating
solution was on average 2.5±0.2% per activation. Mean optimal
sarcomere length derived from polynomial fits was 2.59±0.06 µm.
F–V characteristics of marmoset and human muscle fibres
Using electrophoresis, 77 of all 82 marmoset muscle fibres were
identified as type IIB fibres. As immunohistochemical staining
showed that type IIB MHC is the only isoform expressed in muscle
fibres singularly and hybrid fibres always contain type IIA and IIX
MHC, we considered marmoset muscle fibre segments expressing
one MHC band as pure type IIB muscle fibres (see Fig. 2 for three
typical examples in combination with a rat soleus homogenate).
Of the 52 human fibres analysed, six consisted of type I MHC,
27 consisted of only type IIA MHC, nine consisted of only type
IIX MHC and 10 contained multiple MHCs.
F–V characteristics for each fibre type and species are displayed
in Table 2. As none of the marmoset muscle fibres were similar in
type to the tested human muscle fibres, it was not possible to use a
mixed model analysis with fibre type and species. Therefore, to test
for differences in F–V characteristics between marmoset type IIB
and hybrid fibres, a Student’s t-test was used. To test for differences
in F–V characteristics between different humanmuscle fibre types, a
one-way ANOVA was used. Subsequently, Student’s t-tests were
performed to test for differences between different human and
marmoset fibre types. Within marmoset fibres, the muscle fibre
cross-sectional area (FCSA) was significantly larger in marmoset
type IIB fibres than in marmoset hybrid fibres. ANOVA in human
muscle fibres indicated only a significant main effect for Vmax, with
type I muscle fibres being slower compared with all other human
fibre types (type IIA, IIX and hybrid). Subsequent testing indicated
that marmoset type IIB fibres had a significantly higher muscle fibre
mass-specific peak power output (PFMS,peak) than all human fibre
types. Marmoset hybrid fibres also had a higher PFMS,peak than
human type I, IIA and hybrid fibres. This difference in PFMS,peak
was mainly caused by a significantly higher curvature of Hill’s
relationship (a/P0) in marmoset fibres (both type IIB and hybrid)
compared with that in all human fibre types (I, IIA, IIX and hybrid).
For type IIB marmoset muscle fibres, a/P0 was 3-fold higher than
that for human fibres. Vmax of marmoset type IIB and hybrid muscle
fibres was significantly higher than that of human type I fibres and
significantly lower in marmoset type IIB than in human type IIA
muscle fibres. FCSA of marmoset type IIB fibres was significantly
smaller than that of human type IIA, IIX and hybrid fibres. FCSA of
marmoset hybrid fibres was significantly smaller than that of all
human fibre types. P0, calculated as force divided by FCSA, did
not differ among different fibre types (of both marmoset and
human). However, the question remains to what extent estimates of
PMMS,peak of whole VL and GM of marmosets and humans differ.
Total VL- and GM-specific velocity–force and velocity–power
estimates: marmoset versus human
To estimate PMMS,peak of VL and GM, F–V and P–V curves of both
muscles were estimated. The calculation took the average F–V
characteristics of each fibre type and the fibre-type distribution into
account. Human VL consists of 46.3% type I, 44.3% type IIA and
8.9% type IIX fibres, while human GM consists of 49.4% type I,
42.8% type IIA and 6.6% type IIX fibres (Green et al., 1981).
Unfortunately, we were not able to measure F–V characteristics of
type I muscle fibre segments derived from marmoset muscles.
Instead, we used reported values for F–V parameters of human type
I muscle fibres as conservative estimates for marmoset type I muscle
fibres. Our calculations yielded whole-muscle PMMS,peak of
marmoset VL and GM of more than twice the corresponding
List of symbols and abbreviations
a/P0 curvature of Hill’s relationship
FCSA fibre cross-sectional area
FL fibre length
F–V force–velocity
GM m. gastrocnemius medialis
MHC myosin heavy chain
PBMS,mean body mass-specific mean power
PFMS,peak fibre mass-specific peak power
PMMS,mean muscle mass-specific mean power
PMMS,peak muscle mass-specific peak power
P0 specific tension
P–V power–velocity
VL m. vastus lateralis
Vmax maximal shortening velocity
I IIA/IIX IIA/IIB/IIX IIX/IIA IIB
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80A B Fig. 1. Muscle fibre-type distribution in
marmoset leg muscles. (A,B) Fibre-type
distribution in distal and proximal regions of m.
vastus lateralis (VLdist and VLprox, respectively; A)
and m. gastrocnemius medialis (GMdist and
GMprox, respectively; B). Data are means+s.e.m.,
N=4.
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human values: 8.7 W kg−1 for marmoset VL versus 3.7 W kg−1 for
human VL, and 8.0 W kg−1 for marmoset GM versus 3.5 W kg−1
for human GM (Table 1, Fig. 3).
DISCUSSION
The aim of this study was to investigate whether the 2-fold
difference in in vivo power output (both PBMS,mean and PMMS,mean)
between marmosets and humans is attributable to differences in
muscle contractile properties. We showed that marmoset VL
consists mainly of fast-type muscle fibres (>99.0%), of which the
majority express pure type IIB MHC (63%). Almost all other
muscle fibres express multiple fast MHC isoforms in different
proportions. F–V characteristics differed among fibre types.
Significantly higher PFMS,peak values were found in marmoset
type IIB and hybrid fibres than in human type I, IIA, IIX and hybrid
fibres, mainly because of a significantly higher a/P0 in marmoset.
PMMS,peak of whole VL and GM were estimated by combining
our measured F–V characteristics of skinned single fibre segments
of marmosets and humans with fibre-type distribution in GM and
VL of the marmoset and reported fibre-type distributions in humans,
respectively. The estimates for marmoset VL and GM PMMS,peak
were 2.4 and 2.3 times those for human VL and GM PMMS,peak.
These differences are similar to differences reported for mean power
output (both PBMS,mean and PMMS,mean) delivered during push-off
of a vertical jump. In marmoset, PBMS,mean was 1.9 times and
PMMS,mean 2.4 times that of human (Bobbert et al., 2014). These
results indicate that during a maximal vertical jump the higher in
vivo mean power output (both PBMS,mean and PMMS,mean) delivered
by marmosets compared with that by humans is mainly caused by a
larger proportion of fast muscle fibres in the main leg extensor
muscles of the marmoset.
Some methodological limitations need to be considered
regarding the accuracy of estimates of whole-muscle PMMS,peak
based on the present data and those of the cited studies. First,
biopsies for assessment of F–V characteristics of marmosets were
taken from the middle part of the muscles and biopsies for
assessment of fibre-type distribution from the proximal and distal
parts. Theoretically, it is possible that muscle fibre types were not
homogeneously distributed throughout the muscles. However,
muscle fibre-type distribution in the analysed sections was highly
uniform and no difference was shown between proximal and distal
biopsies. It is therefore unlikely that our estimates are biased as a
result of measurement errors caused by the location of biopsies.
Second, biopsies of marmosets were taken post mortem, whereas
those of humans were sampled in vivo. However, as marmoset
biopsies were taken within 15 min post mortem, it seems highly
unlikely that the results would have been affected by differences in
harvesting conditions. Moreover, if this had influenced the results,
the estimated PMMS,peak of marmosets would be underestimated
rather than overestimated. Third, current estimates for whole-muscle
PMMS,peak reported are still far from values reported for in vivo
PBMS,mean and PMMS,mean. This difference is caused by the fact that
reported PFMS,peak for different fibre types is determined at 15°C
whilst in vivo muscles operate at about 37°C. Making a fair
translation from skinned single fibre segment force characteristics to
whole-muscle force characteristics in vivo requires a comparative
study of the temperature dependence of single muscle fibres. For
such a translational step between ex vivo and in vivo, measurements
with in situ whole muscles seem indicated. Another factor affecting
the estimate of whole-muscle power output is that dissection and
treatment of muscle tissue for determining muscle fibre F–V
characteristics involves permeabilization of muscle fibres and,
whilst suspended in relaxing solution, swelling of the fibre (Degens
and Larsson, 2007). Both the skinning and the swelling of the
muscle fibre may decrease the measured PFMS,peak (Moss, 1979;
Elzinga et al., 1989; Degens and Larsson, 2007). However, these
factors will not affect the conclusions of the current study as a direct
comparison between human and marmoset fibre F–V characteristics
was made using the same method and set-up. Because the protocol,
the solutions used and temperature have a large effect on F–V
characteristics, we refrain from comparing our results with those
obtained in other studies.
Taking all limitations into account, it seems safe to say that
estimated whole-muscle PMMS,peak of VL and GM, calculated on the
basis of muscle fibre-type distributions and fibre F–V
characteristics, are twice as high in marmosets as in humans.
These differences are mainly attributable to differences in the MHC
expression between the two species.
Marmosets have fast muscles and a unique expression of
type IIB MHC
To the best of our knowledge, the present study is the first
to distinguish between fast-type MHC isoforms expressed in
Table 1. Fibre-type distribution, fibre mass-specific peak power and estimated whole-body muscle mass-specific peak power in marmoset and
human m. vastus lateralis (VL) and m. gastrocnemius medialis (GM)
Human Marmoset
Type I Type IIA Type IIX Hybrid Type I Type IIB Hybrid
VL fibre-type distribution (%)a 46.3±3.9 44.3±3.2 8.9±2.3 0.6±0.3 62.7±6.3 36.7±7.4
GM fibre-type distribution (%)a 49.4±2.8 42.8±3.5 6.6±2.6 9.1±3.6 44.3±8.4 46.6±9.4
PFMS,peak (W kg
−1) 2.53±1.36 5.45±0.61 6.51±1.25 5.15±0.75 9.17±0.35 8.90±1.86
VL PMMS,peak (W kg
−1) 3.7 8.7
GM PMMS,peak (W kg
−1) 3.5 8.0
Data are means±s.e.m.
PFMS,peak (fibre mass-specific peak power) was measured in vitro at 15°C; PMMS,peak (muscle mass-specific peak power) was estimated at 15°C.
aHuman values for fibre-type distribution are taken from Green et al. (1981).
Marmoset
hybrid
Marmoset
IIB
Marmoset
IIB
Rat
soleus
IIA/IIX
IIB
I
Fig. 2. Myosin heavy chain (MHC) composition of three marmoset single
muscle fibres and a rat soleus homogenate. Three single muscle fibre
segments were analysed using SDS-PAGE. A hybrid fibre is shown in the left
lane and pure type IIB fibres are shown in the middle two lanes. The right lane
contains a rat m. soleus homogenate as reference.
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non-human primate skeletal muscle. Our study shows that skeletal
muscles of the small marmoset primate expressMHC IIB, like small
rodents such as mouse and rat. Comparison of our findings on
marmoset muscles with those reported in the literature for VL and
GM of other primates reveals some similarities and differences.
Overall, small primates have relatively more fast fibres than large
primates (Ariano et al., 1973; Petter and Jouffroy, 1993; Fitts et al.,
1998; Jouffroy et al., 1999; Myatt et al., 2011; Feng et al., 2012)
(Table 3). Myatt et al. (2011) reported fibre-type distributions in one
orangutan (GM, Pongo abelii) and two chimpanzees (GM, Pan
troglodytes). Orangutan GM had a muscle fibre-type distribution
similar to that of humans, and chimpanzee GM had more fast-type
muscles fibres. In rhesus macaque (Macaca mulatta), both VL and
GM consist mainly of fast muscle fibres (Fitts et al., 1998; Jouffroy
et al., 1999). In green vervet monkeys (Chlorocebus aethiops
sabaeus), VL consists of an even higher percentage of fast fibres
(Feng et al., 2012). In the bushbaby (Galago senegalensis), VL and
GM mainly consist of fast glycolytic muscle fibres (Ariano et al.,
1973), similar to the values reported in the present study for
marmoset muscle. The smallest primate of which the muscle fibre-
type distribution has been studied is the grey mouse lemur
(Microcebus murinus), of which the VL contained only fast
muscle fibres (Petter and Jouffroy, 1993). Taken together, our
findings on muscle fibre-type distributions in marmoset seem to be
in line with values reported in the literature for other primates. In
smaller primate species, VL and GM consist of relatively more fast
muscle fibres than in larger primate species. However, whether
other primates also express type IIBMHC remains to be determined.
An intriguing question is why type IIB MHC is abundantly
expressed in leg muscles of marmosets but not in adult human leg
muscles (Smerdu et al., 1994; Ennion et al., 1995; Pereira Sant’Ana
et al., 1997; Wu et al., 2000; Horton et al., 2001). Type IIB MHC
mRNA expression in human skeletal muscle occurs only at very low
levels; IIB MHC mRNA expression is upregulated only in cases of
severe muscle degeneration/regeneration, but protein levels remain
undetectable (Harrison et al., 2011). The lack of IIB MHC
expression in human skeletal muscle is due to specific, key
promoter sequences of the human gene which differ from those of
the mouse IIB MHC gene (Harrison et al., 2011). These sequences
prevent binding of transcription factors (i.e. serum response factor
and myocyte enhancer factor 2), which enhance transcription of IIB
MHC. In addition, post-transcriptional control also may play a role
(Harrison et al., 2011). It has been suggested that the F–V
characteristics of IIB muscle fibres may be incompatible with the
biomechanical constraints of larger muscles (Pereira Sant’Ana et al.,
1997; Allen et al., 2001). If this applies to the order of primates, it
remains to be determined which other primate species express MHC
IIB like the marmoset and which do not. Comparison of myosin IIB
expression levels and sequence differences in the MHC promoter
will allow determination of the extent to which the ability to express
MHC IIB relates to primate body size. Such insight will improve our
understanding of evolutionary development of the musculo-skeletal
system.
Muscle power-generating capacity: marmoset versus other
(primate) species
Marmoset in vivo mean power output (both PBMS,mean and
PMMS,mean) is about twice as high as that of human. Other primates
seem to have the ability to generate an even higher PBMS,mean or
PMMS,mean during push-off in a vertical jump. For instance, for the
Table 2. Contractile properties of human type I, IIA, IIX and hybrid fibres and marmoset type IIB and hybrid fibres
Species N FCSA (µm2)a P0 (N cm
−2) a/P0
b Vmax (FL s
−1)c
Human type I 6 5100±893* 12.24±2.30 0.10±0.02* 0.33±0.10*
Human type IIA 27 7867±501* 12.26±0.91 0.09±0.00* 0.86±0.03*
Human type IIX 9 6429±821* 12.94±1.78 0.12±0.02* 0.80±0.10*
Human hybrid 10 7659±688* 11.37±0.79 0.10±0.01* 0.80±0.06*
Marmoset type IIB 77 4271±157* 10.90±0.31 0.33±0.02* 0.80±0.02*
Marmoset hybrid 5 2561±586* 12.45±1.42 0.24±0.03* 0.77±0.12*
Data (means±s.e.m.) are shown for fibre cross-sectional area (FCSA), specific tension (P0), curvature of Hill’s relationship (a/P0) and maximal shortening
velocity (Vmax). N, number of fibres.
Significant differences between fibre types are indicated with an asterisk (*P<0.05).
aSignificant differences for FCSA were found between: human type I and marmoset hybrid, human type IIA and marmoset type IIB, human type IIA and
marmoset hybrid, human type IIX and marmoset type IIB, human type IIX and marmoset hybrid, human hybrid and marmoset type IIB, human hybrid and
marmoset hybrid, and marmoset type IIB and marmoset hybrid.
bSignificant differences for a/P0 were found between: marmoset type IIB fibres and all human fibre types (I, IIA, IIX and hybrid), and marmoset hybrid and all
human fibre types (I, IIA, IIX and hybrid).
cSignificant differences for Vmax were found between: human type I fibres and all other fibre types, and human type IIA and marmoset type IIB.
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was derived from the whole-muscle F–V
relationship, which was estimated by adding
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(dashed) and P–V (solid) curve of marmoset
(thick) and human (thin) VL (A) and GM (B).
FL, fibre length.
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bushbaby, power values of 171 W kg−1 PBMS,mean and 683 W kg
−1
PMMS,mean have been calculated from data in the literature (for
references, see Bobbert et al., 2014). These values are 6.3-fold and
3.7-fold those reported for humans, respectively, and 3.3- and 1.6-
fold those shown here for the marmoset. Again, the question arises of
whether this difference in in vivo power-generating capacity is related
to differences in fibre-type distribution and/or muscle fibre F–V
characteristics. As reported above, muscle fibre-type distribution is
likely to be fairly similar in marmosets and bushbabies (Ariano et al.,
1973). However, to the best of our knowledge, as yet no data are
available on the power-generating capacity of bushbaby muscle
fibres. PFMS,peak of different species needs to be compared within the
same experimental set-up using the same solutions in order to make
definitive statements about possible differences in power-generating
capacity. In this context it is interesting to note, as we did before
(Bobbert et al., 2014), that the reported PMMS,mean delivered by
marmosets and bushbabies during a vertical jump is similar to or even
higher than PMMS,peak measured for supramaximally stimulated in
situ rat m. gastrocnemius medialis (i.e. 530 W kg−1 muscle mass) at
35°C (Furrer et al., 2013).
In a recent forward simulation study, it was shown that isometric
downscaling of a human musculoskeletal model to the size of a
marmoset leads to a reduction in jump height from about 40 cm to
about 10 cm, because the F–V relationship limits power and work
production (Bobbert et al., 2014). The higher percentage of fast
muscle fibres in smaller primates and the higher poweroutput is one of
the factors that helps us understand why real marmosets, despite their
small size, actually jump higher than humans (Bobbert et al., 2014).
Further research iswarranted touncovermechanismsunderlying the
differences between in situ and in vitro muscle power measurements
on the one hand, and an animal’s jumping performance in vivo on the
other hand. As a first next step, development of a realistic
musculoskeletal model of the marmoset seems indicated.
Conclusions
The results of this study show that the 2-fold difference observed
in in vivo mean power output (both PBMS,mean and PMMS,mean)
between marmosets and humans is attributable to differences
in muscle fibre contractile properties. This is explained by
marmosets having a higher percentage of fast muscle fibres.
Surprisingly, marmosets seem to be unique amongst primates in
that they have a high percentage of type IIB fibres in leg muscles.
To the best of our knowledge, type IIB MHC expression in leg
muscles fibres has not been reported yet for any other primate
species.
MATERIALS AND METHODS
Marmoset muscle biopsies
Muscle biopsies were obtained within 15 min post mortem from four adult
common marmosets (C. jacchus, three males and one female, age 3.5±
0.5 years, mass 0.343±0.035 kg).
Animals were housed in pairs in spacious cages enriched with climbing
attributes. Intensive veterinary supervision was present during the study. The
facility was under controlled conditions of humidity (>60%), temperature
(22–26°C) and lighting (12 h light:12 h dark cycles). Themarmosetswere fed
daily with pellet chow for New World monkeys (Special Diet Services,
Witham, Essex, UK), enrichedwith peanuts, biscuits, fruit, vegetables and an
occasionalmealworm.Waterwas available ad libitum. Animalswere enrolled
in another project at the Biomedical Primate Research Centre (BPRC)
regarding the effects of Parkinson’s disease. According to the Dutch law on
animal experimentation, the study was approved by the Ethical Review
Committee of the BPRC. For the project regarding effects of Parkinson’s
disease, the animals had received behavioural training and their behaviour
had been monitored weekly. Animals were killed in an early stage of
the induction of Parkinson’s disease and were considered as lightly affected
or not affected by the disease, as judged from behavioral measurements.
Furthermore, post mortem, no sign of neurodegeneration was observed by
immunohistochemical staining of the target brain tissue.
For measurement of muscle fibre F–V characteristics, a small piece
(2×2×5 mm) of muscle tissue was cut from the middle of VL. For
immunohistochemical analysis, biopsies (2×2×5 mm) from VL and GM
were taken from both the distal and proximal parts of each muscle.
Human muscle biopsies
Human muscle biopsies were collected from the VL of nine human subjects
(age 24.3±3.9 years) who were enrolled in a previous study (Salvadego
et al., 2013). All subjects had given their informed consent. The local ethical
committees of the University of Primorska, Koper, Slovenia, approved
obtaining the human biopsies.
Table 3. Literature overview of fibre-type distribution in different (primate) species
Type II
Species Author Mass (kg) Muscle Type I A B X Hybrid Method
Human (Homo sapiens) Green et al., 1981 79.1 VL 46.3 44.3 8.9 ATPase
GM 49.4 42.8 6.6
Chimpanzee (Pan troglodytes)a Myatt et al., 2011 56/62 GM 14/16 83/82 MAb
Orangutan (Pongo abelii) Myatt et al., 2011 42 GM 47 51 MAb
Rhesus macaque (Macaca mulatta) Fitts et al., 1998 9.4 GM 23 24 49 4 MAb
Jouffroy et al., 1999 5–6 VL 15 85 MAb
GM 22 78
Green vervet monkey (Chlorocebus aethiops
sabaeus)
Choi et al., 2012 5.6 VL 79 21 SDS-PAGE
Feng et al., 2012 5.6 VL 6 78 16 ATPase
Marmoset (Callithrix jacchus) Present study 0.34 VL Dist 0.1 68.9 31.0 MAb
VL Prox 1.1 56.5 42.4
GM Dist 8.6 48.0 43.4
GM Prox 9.7 40.6 49.7
Bushbaby (Galago senegalensis) Ariano et al., 1973 0.25–0.31b VL 13 87 ATPase
GM 15 29 56
Grey mouse lemur (Microcebus murinus) Petter and Jouffroy, 1993 VL 47.3 52.7 ATPase
GM 21.8 37.8 40.3
MAb, monoclonal antibodies; Dist, distal; Prox, proximal.
aChimpanzee data are for females/males.
bValues for mass are not reported by Ariano et al. (1973) so values displayed are from Aerts (1998).
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Determination of marmoset fibre-type distribution
Immunohistochemistry
Muscle biopsies were frozen and stored in liquid nitrogen until use. Sections
(10 µm) were cut using a cryostat at –20°C, air dried and stored at−80°C until
use. Fibre-type distributionwas determinedby immunohistochemical staining
ofMHCs.Monoclonal antibodieswere used againstMHC I (BA-D5, 1:1000),
MHC IIA (SC-71, 1:1000), MHC IIB (F30, 1:1000) and MHC IIX (6H1,
1:200) (Developmental Studies Hybridoma Bank, The University of Iowa)
(Miller et al., 1985; Schiaffino et al., 1989; Lucas et al., 2000). Secondary
antibodies against mouse IgG2b (Alexa Fluor 488, 1:200), IgG1 (Alexa Fluor
488, 1:200) and IgM (Alexa Fluor 647, 1:200) (Invitrogen, USA) were used.
Sections were blocked with goat serum (Invitrogen, USA) in phosphate-
buffered saline (PBS) for 30 min at 25°C. Subsequently, sections were
incubated with primary antibody for 60 min followed by incubation with
secondary antibody incubation for 60 min, both at 25°C. Each incubationwas
followed by three 3 min washes in PBS with Tween (PBST) (Sigma-Aldrich,
USA). Cell membranes were visualized by incubation of the sections with
wheat germ agglutinin (WGA, 1:50) (Invitrogen, USA) for 20 min at 25°C
followed by washing 2 times with PBST for 3 min and once with PBS for
3 min. Slides were mounted with Vectashield HardSet containing 4′,6-
diamidino-2-phenylindole (DAPI). Images were captured using a CCD
camera (PCO, Sensicam, Kelheim, Germany) with a 20× objective connected
to a fluorescence microscope (Axiovert 200M, Zeiss, Göttingen, Germany)
with image-processing software (Slidebook 4.1, Intelligent Image
Innovations, Denver, CO, USA). Typical examples of staining of different
MHC isoforms are displayed in Fig. 4.
Data analysis
Per biopsy, MHC expression was assessed in 500 fibres. Fibres were
subdivided into type I and type IIB fibres and the following hybrid forms:
mainly type IIAwith IIX, mainly type IIB with IIA and IIX, and mainly type
IIX with IIA.
F–V characteristics of human and marmoset skinned single
muscle fibre segments
Solutions
Solutions were as described previously (Larsson and Moss, 1993; Degens
and Larsson, 2007; Degens et al., 2010). Relaxing solution contained
(mmol l−1): MgATP 4.5, free Mg2+ 1, imidazole 10, EGTA 2 and KCl 100;
pH was adjusted to 7.0 with KOH. Activating solution (pCa 4.5) contained,
in addition to Ca2+ (mmol l−1): MgATP 5.3, free Mg2+ 1, imidazole 20,
EGTA 7, creatine phosphate 19.6 and KCl 64; pH 7.0.
Preparation of muscle biopsies
Muscle biopsies were cut into small bundles and immersed for 24 h in a 50%
glycerol, 50% relaxing solution at 4°C. For prolonged storage, muscle fibre
bundleswere treated in relaxing solutionwith increasing sucrose concentration
and were stored in 2 mol l−1 sucrose at −80°C until further analysis (Frontera
and Larsson, 1997). Prior to analysis, biopsies were desucrosed and stored in
glycerol/relaxing solution at −20°C and used within 1 month.
Preparation of skinned single muscle fibre segments
Single muscle fibre segments were prepared as described previously
(Larsson and Moss, 1993; Gilliver et al., 2011). In summary, the muscle
fibre bundles were placed for 20 min in relaxing solution containing 1%
Triton X-100 to permeabilize the membranes and sarcoplasmic reticulum.
Single fibre segments were extracted from the bundles in the relaxing
solution and mounted in a permeabilized fibre test system (400, Aurora
Scientific Inc., Aurora, ON, Canada). Each fibre segment was then attached
with nylon thread to fine insect pins mounted on a force transducer (403A,
Aurora Scientific Inc.) and motor arm (312C, Aurora Scientific Inc.). The
force transducer and motor arm were mounted over a moveable plate
containing a set of wells, with a glass base. The platewas cooled to 15°C and
the set-up (plate, force transducer and motor) was mounted on an inverted
microscope (Olympus IX71, Tokyo, Japan). The average sarcomere length
A B
C D
IIA/B/X
IIA/B/X IIA/B/X
IIA/B/X
IIX/A
IIX/A
I I
I I
IIX/A
IIX/A
IIA/X
IIA/X
IIA/X
IIA/X
IIB
IIB
IIB
IIB
Fig. 4. Immunofluorescence images of
marmoset GM. Serial sections were stained
(green) with monoclonal antibodies against
MHC I (A), MHC IIA (B), MHC IIB (C) and MHC
IIX (D). Nuclei were stained with DAPI (blue)
and cell membranes were stained with wheat
germ agglutinin (WGA, red). Scale bar
indicates 100 µm.
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was determined using a Fourier transformation of the sarcomere striation
pattern (900A, Aurora Scientific Inc.). Fibre segment length was adjusted to
optimum sarcomere length.
Prior to the F–Vmeasurements, the diameter of the muscle fibre segment
was assessed at three locations along its length while being submerged in
relaxing solution. Fibre width was measured in liquid, assuming a circular
circumference. Fibre diameter measured in air and liquid are closely
correlated (R2≈0.90) (Degens and Larsson, 2007). In order to be able to
compare data of this study with those from others that measured fibre CSA
while the fibre was suspended in air, values for FCSA, P0 and Ppeak were
multiplied by 1.25 (Degens and Larsson, 2007). No correction was made for
swelling of the fibre during skinning. Fibre segment length was measured to
the nearest 0.01 mm.
Determination of marmoset optimal sarcomere length
For marmoset muscle fibre segments, optimum sarcomere length had to be
determined. Optimum sarcomere length was determined in five fibre
segments by repeatedly moving the segments from relaxing to activating
solution at randomly determined sarcomere lengths around 2.6 µm. To
correct for force decrements due to switching between relaxing and activating
solution, a least squares linear regression linewas fitted to the force data over
activations. The slope of this line shows the average decrement in force after a
transfer of the muscle fibre from relaxing to activating solution. Using this
slope, force data were corrected for this force decrement.
Determination of contractile properties
To determine contractile properties of muscle fibre segments, a fibre
was transferred from relaxing solution into activating solution (pCa2+
4.5 mmol l−1) and, once an isometric force plateau was reached, subjected
to four sequences of four isotonic shortening steps, as described elsewhere
(Bottinelli et al., 1996) (Fig. 5A,B). During each sequence, the lever arm
moved at a speed sufficient to maintain muscle fibre force at a predetermined
percentage of its isometric force. Each sequence consisted of four force steps
(each 150 ms long). Force levels ranged from 0.90 to 0.05 of maximal
isometric force. Following each sequence, fibre segments were rapidly
re-stretched to their original lengthswhile still in activating solution. This rapid
re-stretch was shown to help maintain sarcomere integrity and maintain
stability of the muscle fibre segments during long series of contractions
(Brenner, 1983). During isotonic shortening protocols,maximal shortening of
fibre segments was less than 20% of the initial length.
Determination of MHC composition of skinned single muscle fibre
segments
After determination of muscle fibre contractile characteristics, fibre
segments were stored in sodium dodecyl sulphate (SDS) sample buffer
and kept at −20°C if MHC typing was performed within a week or at−80°C
if this occurred more than a week after the contractile measurements. All
chemicals were obtained from Sigma-Aldrich (The Netherlands) unless
stated otherwise. Before analysis, samples were denatured at 100°C for
2 min. MHCs were separated using SDS-PAGE as previously described
(Larsson and Moss, 1993; Degens and Larsson, 2007; Degens et al., 2010).
Briefly, samples were separated for 27 h at 275 V on a 7% polyacrylamide
gel containing 35% glycerol. Gels were stained using a Silverstain Plus kit
(Bio-Rad, Hemel Hempstead, UK). MHC isoforms were identified based on
migration distances of the proteins. Human fibres were subdivided into pure
type I, pure IIA, pure IIX and hybrid fibres. Marmoset fibres were
subdivided in pure type IIB fibres and hybrid fibres. Single bands were
considered to identify pure type IIB fibres while multiple bands identified
hybrid fibres.
Data analysis
Force and length data were analysed as described previously (Gilliver et al.,
2009). Force was averaged over the last 50–120 ms. Shortening velocity was
calculated by fitting a least squares linear regression line to the same last
50–120 ms of the length trace. The force and velocity data points were used
to fit a hyperbolic Hill equation (Hill, 1938) using a non-linear least-squares
regression (Fig. 5C). This fit yielded Hill constants a and b, which together
with specific tension (P0 in N cm
−2), were used to estimate maximal
unloaded shortening velocity of muscle fibre segments [Vmax in fibre lengths
(FL) s−1]. The fraction (M ) of maximal force (P0) or shortening velocity
(Vmax) at which muscle fibre peak power (PFMS,peak) was generated was
derived from Hill’s equation as:
M ¼ ð ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1þ G  1p Þ=G;
where G is P0/a or Vmax/b (Woledge et al., 1985). PFMS,peak was calculated
as M2×P0×Vmax.
Data were rejected if during the isotonic protocol the isometric force
decreased by more than 10% and/or sarcomere length at rest changed by
more than 0.1 µm and/or if R2 for Vmax was <0.96 when fitting Hill’s
equation to the data.
Human and marmoset total VL and GM peak power estimates
Using relative proportions of muscle fibre types in VL and GM and
their contractile characteristics for both humans and marmosets, PMMS,peak
(in W kg−1 muscle) was estimated for whole VL and GM. For fibre-type
distributions of human VL and GM, we used data reported in the literature
(Green et al., 1981). PMMS,peak was derived from the whole-muscle F–V
relationship, which was estimated by adding at each velocity the force output
of the relative fractions of different fibre types.
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Fig. 5. Typical examples of muscle fibre
segment F–Vmeasurements. (A) Muscle fibre
relative force during the four isotonic shortening
sequences. (B) Muscle fibre relative length
during the four isotonic shortening sequences.
(C) Using the average force (over the last
50–120 ms) and shortening velocity (incline of
fibre fragment length in the same period) of each
of the 16 isotonic force levels, a Hill curve was
fitted.
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Statistics
To test whether the muscle fibre-type distribution differed between muscles
and regions, datawere submitted to a 2×2mixedmodel design ANOVAwith
between-subjects factor muscle (VL and GM) and within-subjects factor
regions (distal and proximal).
ANOVA and Student’s t-tests were performed to test whether F–V
outcome variables were significantly different between muscle fibre types.
All data were analysed using SPSS statistics. Values are presented as
means±s.e.m. Differences were considered significant at P<0.05.
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